SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
SYNTHETECH - NZYM
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
372 14 0 NZYM
Emcee:  Peter Caradonna Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
247 That assessment is clearly from a business case only. NZYM had a technical breScott H. Davis-11/27/1998
246 If it gets back to the 4s it will be an even better buying opportunity. Greg, Dan Gibbs-11/27/1998
245 My interpretation would be a fairly normal retracement after a strong runnup. Scott H. Davis-11/26/1998
244 Dan, Maybe I'm missing something, but I bought a bit more when it hit $5 1gregory a weaver-11/25/1998
243 When NZYM got down to $5.50 today, the PE dipped to 29 (down from recent PE'Dan Gibbs-11/25/1998
242 I made my annual visit to Synthetech today. Briefly, things seem to be going vDan Gibbs-11/16/1998
241 I think you are both right. From here on out you should see an increase in revecliff emohs-11/12/1998
240 Mike..I agree with your analysis that the stock is now undervalued. My guess iJohn McDonald-11/12/1998
239 Looking back over the last 6 years, the average annual low PE is 23, the averagMike Mansour-11/12/1998
238 She'z comin around!! eom.John McDonald-11/10/1998
237 Revenues and earnings are better than expected. What is even more exciting is Dan Gibbs-11/10/1998
236 Earnings released after close today look great! Tomorrow should be interesting.Mike Mansour-11/10/1998
235 If the recent buying activity is an indication I bet you are right about earninJohn McDonald-11/4/1998
234 2nd quarter earnings should be announced next week. My guess is that they willDan Gibbs-11/4/1998
233 Very reasonable. My thought process was identical to yours. Dan Gibbs-8/18/1998
232 Dan, thanks for the response. Appears it was a reasonible speculation tho. Scott H. Davis-8/14/1998
231 I was sure that Agouron's viracept used NZYM's building blocks and I thDan Gibbs-8/14/1998
230 A conjecture on a customer. I'm reading thru the annual report, and severaScott H. Davis-8/13/1998
229 Synthetech Reports Higher Revenues & Earnings for First Quarter of Fiscal 1John McDonald-8/12/1998
228 At the last minute, I was unable to go to the annual meeting today. Did anyoneDan Gibbs-7/23/1998
227 Mike - I thought that paragraph was the highlight of the annual report. The otTim-7/21/1998
226 Mike, thanks for the tip. Scott Scott H. Davis-7/21/1998
225 According to their Annual Report the split in 1998 was 41% in Clinical Trials, Mike Mansour-7/21/1998
224 NZYM has always been very careful to respect the wishes of its customers not toDan Gibbs-7/20/1998
223 To All: I'm looking at NZYM as a potential investment. My main focus now iScott H. Davis-7/14/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News